Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
Date:11/9/2009

25,194 956 OPERATING EXPENSES: Cost of services -- 13 -- 27 Research and development: Non-cash compensation 388 334 950 (395) Other research and development 1,527 2,208 4,357 37,277 -------------------------------------------- Total research and development 1,915 2,542 5,307 3,882 -------------------------------------------- Selling, general and administrative: Non-cash compensation 250 1,662 1,648 5,146 Other selling, general and administrative 904 2,284 3,473 6,249 -------------------------------------------- Total selling, general and administrative 1,154 3,946 5,121 11,395 -------------------------------------------- TOTAL OPERATING EXPENSES 3,069 6,501 10,428 48,304 -------------------------------------------- OPERATING INCOME (LOSS) 431 (6,133) 14,766 (47,348) OTHER INCOME (EXPENSE): Interest and other income (expense), net 129 (622) 377 (1,551) -------------------------------------------- INCOME (LOSS) FROM CONTINUING OPERATIONS 560 (6,755) 15,143 (48,899) Loss from discontinued operations -- (86) -- (175) -------------------------------------------- NET INCOME (LOSS) $ 560 $(6,841) $15,143 $(49,074) ============================================ NET INCOME (LO
'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
3. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
4. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
5. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
6. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
7. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
8. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
9. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
10. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
11. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... TUCSON, Ariz. , March 31, 2015  SynCardia ... Investigational Device Exemption (IDE) clinical study on the effective ... The ... with as many as 30 heart failure patients. Patients ... Total Artificial Heart as a bridge to a donor ...
(Date:3/31/2015)... MedSpring Urgent Care is pleased to announce the opening of its ... Upper Greenville. The center – located at 4844 Greenville Avenue – ... Knox - Henderson , its first DFW ... last fall. Additional Dallas metroplex locations are ... and Las Colinas neighborhoods this summer. "We are excited ...
(Date:3/31/2015)... -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ("Galmed"), ... and commercialization of a once-daily, oral therapy for ... today announced financial results for the 12 months ... 2014 Highlights: , Hosted a key opinion ... Rohit Loomba, MD, MHSc., who discussed the topic ...
Breaking Medicine Technology:FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4MedSpring Urgent Care Opens New Upper Greenville Location in Dallas 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 4Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 5Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 6Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 7Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 8
... 12, 2007 /PRNewswire-FirstCall/ --,InB:Biotechnologies, Inc. ("BioTech"), a ... announced strong positive,results in studies of vaccines ... novel, proprietary AIPwLV(TM) vaccine technology. The,studies were ... Molecular,Biotechnology (CMB), the Contract Research Organization led ...
... LUND, Sweden, March 13, 2007--Active Biotech AB,(Stockholm:ACTI.ST) ... a first human micro-dosing trial of an,I-3D ... was to determine the pharmacokinetic,characteristics of the ... healthy volunteers. , The study demonstrated that ...
Cached Medicine Technology:Integrated Biopharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2Active Biotech's I-3D Micro-dosing Clinical Trial Concluded 2
(Date:3/31/2015)... York, New York (PRWEB) March 31, 2015 ... Disease Association (APDA) is proud to announce 30 Days, 30 ... to learn about this month-long campaign that will offer a ... impact in the lives of those who battle this disease. ... diagnosis, which means that in April alone nearly 5,000 individuals ...
(Date:3/31/2015)... 2015 Dr. François Blaudeau, the founder ... in a power morcellator lawsuit filed on ... result of metastatic leiomyosarcoma, a rare and aggressive form ... was filed by her husband and is currently pending ... alleges that the power morcellator used during her March ...
(Date:3/31/2015)... Beckman Coulter is sponsoring a new ... Demeler, which will highlight approaches used to extract more ... to attend and will be broadcast live April 16, ... new methods for sedimentation data analysis have ... a wide range of technology sectors, including life science ...
(Date:3/31/2015)... Denver, Colorado (PRWEB) March 31, 2015 ... Regional Transportation District (RTD) are planning an array of ... petition, a Signature Bus Tour and a Unity Parade ... “Stand Up for Transportation Day” – a national day ... support for long-term, sustainable transportation funding. , The effort ...
(Date:3/31/2015)... Vegas, NV (PRWEB) March 31, 2015 ... of the most important ligaments in the leg providing ... Researchers presenting their study at today’s Specialty Day meeting ... AOSSM ) utilized MRI data to determine the potential ... “Little is currently understood about the healing of meniscus ...
Breaking Medicine News(10 mins):Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 3Health News:Power Morcellator Lawsuit Filed by Southern Med Law Alleges Wife’s Death Resulted from Cancer Spread via Uterine Morcellation 2Health News:Power Morcellator Lawsuit Filed by Southern Med Law Alleges Wife’s Death Resulted from Cancer Spread via Uterine Morcellation 3Health News:Beckman Coulter Webinar Series Presents Advances in Sedimentation Analysis 2Health News:Beckman Coulter Webinar Series Presents Advances in Sedimentation Analysis 3Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 2Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 3Health News:New Way to Evaluate Meniscus Tear Outcomes 2
... RONKONKOMA, N.Y., July 10 NBTY, Inc. (NYSE: NTY ... marketer of nutritional supplements, today announced that it will web cast ... NBTY, at the Oppenheimer 9th Annual Consumer, Gaming, Lodging & Leisure ... The presentation is scheduled to be web cast live on the ...
... Recently, ... during the Anatomy 200 module of their Massage Therapy program at CNI College prepared them ... the main focus in this module. , ... Orange, CA (PRWEB) July 10, 2009 -- Recently, students attended a lab at ...
... ... now a featured expert on searchhearthealth.com, a new informational Web site devoted to all aspects ... Potomac, ... alternative health movement, is now a featured expert on searchhearthealth.com , a new informational ...
... , LA JOLLA, Calif., July 9 TorreyPines Therapeutics, Inc. ... was convened on July 9, 2009, was adjourned to July ... located at 11085 North Torrey Pines Road, Suite 300, La ... to stockholders on or about June 19, 2009, the stockholders ...
... Congressman Chaka Fattah (D-PA), Chairman of the Congressional Urban ... jurisdiction over health policy prepare to introduce legislation on health ... opportunity is at hand for the House of Representatives to ... on all members of the Congressional Urban Caucus to stand ...
... (Nasdaq: CDIC ), the innovator and leader of BioZ(R) ... quarter 2009. Highlights include 11% sequential revenue increase over Q1 ... consecutive quarter of year over year sensor growth. , ... Second Quarter 2008 , , , ...
Cached Medicine News:Health News:NBTY to Webcast Presentation at Oppenheimer 9th Annual Consumer, Gaming, Lodging & Leisure Conference; Announces Fiscal Third Quarter Preliminary Unaudited Net Sales Results 2Health News:NBTY to Webcast Presentation at Oppenheimer 9th Annual Consumer, Gaming, Lodging & Leisure Conference; Announces Fiscal Third Quarter Preliminary Unaudited Net Sales Results 3Health News:NBTY to Webcast Presentation at Oppenheimer 9th Annual Consumer, Gaming, Lodging & Leisure Conference; Announces Fiscal Third Quarter Preliminary Unaudited Net Sales Results 4Health News:CNI College Massage Therapy Students Experience Plastination & Cadaver Lab 2Health News:Dr. Julian Whitaker Featured on Searchhearthealth.com 2Health News:TorreyPines Announces the Adjournment of Its Special Meeting of Stockholders 2Health News:TorreyPines Announces the Adjournment of Its Special Meeting of Stockholders 3Health News:Urban Caucus Chair Urges Caucus Members to 'Get the Job Done' for Health Care Reform 2Health News:CardioDynamics Reports Second Fiscal Quarter 2009 Results 2Health News:CardioDynamics Reports Second Fiscal Quarter 2009 Results 3Health News:CardioDynamics Reports Second Fiscal Quarter 2009 Results 4Health News:CardioDynamics Reports Second Fiscal Quarter 2009 Results 5
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
ISI Alumi-Hand is the safe, sterile, ready-to-use ,surgical hand immobilizer....
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
ISI Self-Supporting Arm Table offers the easy accessibility for surgeons, technicians and equipment during upper extremity surgeries....
Medicine Products: